<ѻýҕl>CAR T-Cell Therapy Shows Promise in Advanced Kidney Cancerѻýҕl> ORR of 30% in patients with CD70-positive disease using off-the-shelf, allogeneic product Apr 19, 2023
<ѻýҕl>Many With Cancer Predisposition Diseases Unaware of Genetic Statusѻýҕl> Moreover, a significant proportion do not qualify for genetic screening under current guidelines Apr 19, 2023
<ѻýҕl>Risks Outweigh Benefits for BSO at Benign Hysterectomy in Younger Womenѻýҕl> It's less clear-cut for postmenopausal women, study authors say Apr 18, 2023
<ѻýҕl>Robust PSA Drops With Radionuclide Therapy in Castration-Resistant Prostate Cancerѻýҕl> All but one patient had a PSA decline after a fractionated dose of 225Ac-J591 Apr 18, 2023
<ѻýҕl>Novel Antibody Induces Durable Responses in Heavily Pretreated Myelomaѻýҕl> Overall response rate of 90% in patients who received highest doses of REGN5459 Apr 18, 2023
<ѻýҕl>Novel Bispecific Antibody Active in Recurrent/Metastatic Head and Neck Cancerѻýҕl> Responses in 37% of patients previously treated with anti-PD-1/L1 agents, platinum chemotherapy Apr 18, 2023
<ѻýҕl>Responses to PD-1 Blockade Approach 90% in Rare Melanomaѻýҕl> "One of the highest tumor response rates we've seen in any cancer," study discussant says Apr 17, 2023
<ѻýҕl>Including Anti-PD-1 in First-Line Ups Survival in Biliary Tract Cancerѻýҕl> Another option for difficult-to-treat disease Apr 17, 2023
<ѻýҕl>'Potential' New Option for Operable NSCLCѻýҕl> Adding perioperative durvalumab to neoadjuvant chemo improved pCR rates, event-free survival Apr 17, 2023
<ѻýҕl>Adjuvant Combo May Change Practice in High-Risk Liver Cancerѻýҕl> Atezolizumab-bevacizumab reduced the risk of recurrence by about 30% Apr 17, 2023
<ѻýҕl>Personalized Cancer Vaccine Boosts Recurrence-Free Survival in Melanomaѻýҕl> Clinical implications apply to virtually all solid tumors and possibly hematologic malignancies Apr 17, 2023
<ѻýҕl>Taxane, Anthracycline Combo Most Effective in Reducing Breast Cancer Recurrenceѻýҕl> Chemotherapy regimens with higher cumulative dose provide greatest benefit Apr 14, 2023
<ѻýҕl>Oral Drug Improves Sunlight Tolerance in Genetic Photosensitivity Disordersѻýҕl> Dersimelagon significantly extended time to sun-related prodromal symptoms Apr 12, 2023
<ѻýҕl>Blood Donor's Sex Makes No Difference for Survivalѻýҕl> Only difference seen was higher incidence of MRSA infection in recipients of female donor blood Apr 12, 2023
<ѻýҕl>Older Men Still Overscreened for Prostate Cancer, Survey Saysѻýҕl> PSA screening rates over 50% for men 70 and up, despite USPSTF recommendations against it Apr 11, 2023
<ѻýҕl>SYK Inhibitor Promising in Early Trial of Primary ITPѻýҕl> Sovleplenib demonstrated "consistent response" as second-line treatment Apr 11, 2023
<ѻýҕl>Local Anesthesia Before Breast Cancer Surgery Improves OS in Randomized Trialѻýҕl> Intervention is inexpensive, easy to implement, researchers say Apr 07, 2023
<ѻýҕl>Leading Causes of Death Hit Childhood Cancer Survivors Earlierѻýҕl> But excess risk lowest in survivors with a healthy lifestyle Apr 06, 2023
<ѻýҕl>CAR T-Cell Therapy Feasible, Safe in Advanced Neuroblastomaѻýҕl> ORR of 63% with GD2-targeting product in kids with relapsed, refractory high-risk disease Apr 06, 2023
<ѻýҕl>Major Survival Gain With Immunotherapy in Lymphomatoid Granulomatosisѻýҕl> Median overall survival reached 20 years with interferon alfa-2b in low-grade disease Apr 05, 2023
<ѻýҕl>Does Your 80-Year-Old Patient Really Need That Colonoscopy?ѻýҕl> Physicians often ignore life expectancy in screening decisions, study finds Apr 04, 2023
<ѻýҕl>FDA Greenlights New First-Line Regimen in Bladder Cancerѻýҕl> Enfortumab vedotin plus pembrolizumab approved for cisplatin-ineligible patients Apr 04, 2023
<ѻýҕl>Post-Immunotherapy Combo Promising in Advanced RCCѻýҕl> Duration of response reaches 18.6 months with belzutifan plus cabozantinib Apr 03, 2023
<ѻýҕl>VTE Risk in Recurrent Ovarian Cancer Increases With More Lines of Chemotherapyѻýҕl> Prospective study in heavily treated population is warranted, researcher says Mar 30, 2023
<ѻýҕl>Obesity's Impact on Uterine Cancer Risk Greater in Younger Age Groupsѻýҕl> Overall risk and risk of endometrioid subtype 20- to 30-fold greater in women younger than 35 Mar 30, 2023
<ѻýҕl>A 'Double Whammy' for Gastric Cancer Riskѻýҕl> H. pylori infection and certain pathogenic variants linked with large excess risk Mar 29, 2023
<ѻýҕl>Phase III Trials 'Hit a Home Run' in Advanced Endometrial Cancerѻýҕl> Adding immunotherapy will change frontline treatment, experts say Mar 28, 2023
<ѻýҕl>Novel Strategies Show Winning Potential in Ovarian Cancerѻýҕl> High response rates in small studies of immuno-oncology combination, neoadjuvant olaparib Mar 28, 2023
<ѻýҕl>High Out-of-Pocket Costs Tied to Less Follow-Up After Initial Mammographyѻýҕl> Plans dominated by copays and deductibles are associated with higher out-of-pocket costs Mar 27, 2023
<ѻýҕl>No Survival Benefit With CRT Versus Chemo for Locally Advanced Endometrial Cancerѻýҕl> Long-running clinical trial failed to identify any subgroup that fared better with CRT Mar 27, 2023
<ѻýҕl>FDA Greenlights First Drug for Rare Immunodeficiency Diseaseѻýҕl> Activated PI3K-delta syndrome may have a new standard of care Mar 27, 2023
<ѻýҕl>Make the Diagnosis: This Bump on His Nose is a Tricky Diagnosisѻýҕl> A 52-year-old man visited his doctor for a new growth on his nose. Can you diagnosis the patient? Mar 27, 2023
<ѻýҕl>CRT Regimen Boosts Complete Response Rate in Unresectable Vulvar Cancerѻýҕl> Pathologic response rises to 73% versus 50% in historical control group Mar 27, 2023
<ѻýҕl>CDK4/6 Inhibition Active in Recurrent Low-Grade Serous Ovarian Cancerѻýҕl> Responses in a fourth of patients, clinical benefit in up to 90% Mar 26, 2023
<ѻýҕl>Sam Neill's Rare Lymphomaѻýҕl> The actor noticed swollen glands while on tour for "Jurassic World Dominion" Mar 23, 2023
<ѻýҕl>Progestin-Only Birth Control Linked to Small Increase in Breast Cancer Riskѻýҕl> But risk is similar to combined hormonal contraceptive use Mar 22, 2023
<ѻýҕl>FDA OKs Another PD-1 Inhibitor for Merkel Cell Carcinomaѻýҕl> Retifanlimab produced responses in 52% of patients with untreated unresectable disease Mar 22, 2023
<ѻýҕl>Cancer Transmission From Organ Donors With Brain Tumors Not Much of a Riskѻýҕl> In U.K. cohort study, no cases of transmission observed Mar 22, 2023
<ѻýҕl>Sickle Cell Disease Patients Miss Out on Decades of Lifeѻýҕl> What effects might emerging therapies have on real-world survival? Mar 17, 2023
<ѻýҕl>FDA Allows Lower Risk Designation for Snuff Productѻýҕl> The brand joins a limited few granted modified risk tobacco claims Mar 16, 2023